Table 2.
Polygenic risk scoresa, mean (SD) | SCZ | BD | HC | P valueb | SMD vs HC |
---|---|---|---|---|---|
Autoimmune diseases and CRP | |||||
CD | 0.04 (1.0) | 0.03 (0.9) | −0.07 (1.0) | 0.18 | n/a |
IBD | 0.01 (1.0) | −0.04 (1.0) | 0.05 (1.0) | 0.13 | n/a |
PSOR | −0.03 (0.9) | −0.04 (0.9) | 0.08 (0.9) | 0.06 | HC > SMD |
RA | −0.002 (1.0) | −0.04 (1.0) | −0.02 (1.0) | 1.0 | n/a |
SLE | −0.03 (0.8) | −0.05 (0.7) | −0.12 (0.7) | 0.74 | n/a |
T1D | 0.05 (0.8) | 0.10 (0.8) | 0.06 (0.8) | 0.12 | n/a |
CRP | −0.02 (0.9) | 0.00 (0.9) | −0.04 (0.9) | 0.84 | n/a |
Mental disorders | |||||
ADHD | 0.05 (1.0) | 0.11 (1.0) | −0.09 (0.9) | <0.001 | SMD > HC |
ANX | 0.17 (1.0) | 0.12 (0.9) | −0.09 (1.0) | <0.001 | SMD > HC |
ASD | 0.03 (1.1) | 0.08 (1.1) | −0.01 (1.0) | 0.15 | n/a |
MDD | 0.06 (1.0) | 0.01 (1.0) | −0.08 (1.0) | 0.04 | SMD > HC |
PTSD | 0.05 (1.0) | −0.02 (0.9) | −0.11 (0.9) | 0.002 | SMD > HC |
Cognitive traits | |||||
COG | −0.08 (1.0) | 0.02 (1.0) | 0.07 (1.0) | 0.02 | HC > SMD |
EA | 0.11 (1.0) | 0.08 (1.0) | 0.17 (1.0) | 0.10 | HC > SMD |
Personality traits | |||||
EXTRA | 0.04 (1.0) | 0.05 (1.0) | −0.02 (1.0) | 0.16 | n/a |
NEURO | 0.01 (1.0) | −0.04 (1.0) | −0.08 (1.0) | 0.16 | n/a |
OPEN | 0.10 (1.0) | 0.03 (1.0) | −0.01 (1.0) | 0.10 | SMD > HC |
ADHD attention-deficit hyperactivity disorder, ANX anxiety, ASD autism spectrum disorder, BD bipolar spectrum disorders, CD Crohn’s disease, COG cognition, CRP C-reactive protein, EA educational attainment, EXTRA extraversion, HC healthy controls, IBD inflammatory bowel disease, MDD major depressive disorder, n/a not applicable, NEURO neuroticism, OPEN openness, PC principal component, PSOR psoriasis, PTSD post-traumatic stress disorder, RA rheumatoid arthritis, SCZ schizophrenia spectrum disorders, SD standard deviation, SMD severe mental disorders (SCZ and BD), SLE systemic lupus erythematosus, T1D type 1 diabetes.
aStandardized values.
bP value of SMD vs HC: ANCOVA with adjustments for PC1, PC2, and genetic batch.